Prognostic significance of tumor regression grading following preoperative chemoradiotherapy for rectal cancer in the CAO/ARO/AIO-04 randomised trial

被引：0

作者：

Roedel, C. ^{[1
]}

Fietkau, R. ^{[2
]}

Hohenberger, W. ^{[3
]}

Hothorn, T. H. ^{[4
,5
]}

Wolff, H. A.

Stroebel, P. ^{[6
]}

Hess, C. F. ^{[5
]}

Graeven, U. ^{[7
]}

Fokas, E. ^{[8
]}

Arnold, D. ^{[9
]}

Liersch, T. ^{[10
]}

Ghadimi, M. ^{[10
]}

Sauer, R. ^{[2
]}

Wittekind, C. ^{[11
]}

机构：

[1] Goethe Univ Frankfurt, Dept Radiotherapy & Radiat Oncol, D-60054 Frankfurt, Germany

[2] Univ Erlangen Nurnberg, Dept Radiat Therapy, D-91054 Erlangen, Germany

[3] Univ Erlangen Nurnberg, Dept Surg, D-91054 Erlangen, Germany

[4] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland

[5] Univ Med Ctr Gottingen, Dept Radiotherapy, Gottingen, Germany

[6] Univ Med Ctr Gottingen, Inst Pathol, Gottingen, Germany

[7] Kliniken Maria Hilf GmbH Monchengladbach, Dept Hematol Oncol & Gastroenterol, Monchengladbach, Germany

[8] Goethe Univ Frankfurt, Dept Radiotherapy & Oncol, D-60054 Frankfurt, Germany

[9] Tumor Biol Ctr Freiburg, Freiburg, Germany

[10] Univ Med Ctr Gottingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany

[11] Univ Leipzig, Inst Pathol, D-04109 Leipzig, Germany

来源：

STRAHLENTHERAPIE UND ONKOLOGIE | 2015年 / 191卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V-01-03

引用

页码：S4 / S5

页数：2

共 50 条

[21] Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial
Kitz, Julia
Fokas, Emmanouil
Beissbarth, Tim
Stroebel, Philipp
Wittekind, Christian
Hartmann, Arndt
Rueschoff, Josef
Papadopoulos, Thomas
Roesler, Elisabeth
Ortloff-Kittredge, Peter
Kania, Ulrich
Schlitt, Hans
Link, Karl-Heinrich
Bechstein, Wolf
Raab, Hans-Rudolf
Staib, Ludger
Germer, Christoph-Thomas
Liersch, Torsten
Sauer, Rolf
Roedel, Claus
Ghadimi, Michael
Hohenberger, Werner
JAMA SURGERY, 2018, 153 (08)
[22] Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: Results of the German CAO/ARO/AIO-04 randomized phase III trial
Roedel, C.
Liersch, T.
Becker, H.
Fietkau, R.
Hohenberger, W.
Hothorn, T.
Graeven, U.
Arnold, D.
Raab, H. -R
Wittekind, C.
Staib, L.
Hess, C.
Grabenbauer, G.
Sauer, R.
STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 5 - 5
[23] Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial
Fokas, E.
Fietkau, R.
Hartmann, A.
Hohenberger, W.
Gruetzmann, R.
Ghadimi, M.
Liersch, T.
Stroebel, P.
Grabenbauer, G. G.
Graeven, U.
Hofheinz, R-D
Koehne, C-H
Wittekind, C.
Sauer, R.
Kaufmann, M.
Hothorn, T.
Roedel, C.
ANNALS OF ONCOLOGY, 2018, 29 (07) : 1521 - 1527
[24] Impact of age on the efficacy of oxaliplatin in the perioperative chemo(radio)therapy of rectal cancer: A post hoc analysis of the CAO/ARO/AIO-04 phase 3 trial
Hofheinz, R-D
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 123 - 123
[25] Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial
Roedel, C.
Becker, H.
Fietkau, R.
Graeven, U.
Hohenberger, W.
Hothorn, T.
Lang-Welzenbach, M.
Liersch, T.
Staib, L.
Christiansen, H.
Wittekind, C.
Sauer, R.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
[26] Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial
Diefenhardt, Markus
Ludmir, Ethan B.
Hofheinz, Ralf-Dieter
Ghadimi, Michael
Minsky, Bruce D.
Roedel, Claus
Fokas, Emmanouil
JAMA ONCOLOGY, 2020, 6 (09) : 1416 - 1421
[27] Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: Results of the German CAO/ARO/AIO-04 randomized phase III trial.
Rodel, Claus
Liersch, Torsten
Fietkau, Rainer
Hohenberger, Werner
Graeven, Ullrich
Hothorn, Torsten
Arnold, Dirk
Raab, Hans-Rudolf
Wittekind, Christian
Hess, Clemens F.
Staib, Ludger
Becker, Heinz
Sauer, Rolf
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[28] Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial
Roedel, C.
Becker, H.
Fietkau, R.
Graeven, U.
Hohenberger, W.
Hothorn, T.
Lang-Welzenbach, M.
Liersch, T.
Staib, L.
Christiansen, H.
Wittekind, C.
Sauer, R.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[29] Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin in rectal cancer: Initial results of the CAO/ARO/AIO-04 study [Präoperative Radiochemotherapie und postoperative Chemotherapie mit 5-FU und Oxaliplatin bei Rektumkarzinom: Erste Ergebnisse der CAO/ARO/AIO-04-Studie]
Reibetanz J.
Germer C.-T.
Der Chirurg, 2012, 83 (11): : 995 - 995
[30] Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin vs. 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial
Roedel, C.
Larsch, T.
Becker, H.
Fietkau, R.
Hohenberger, W.
Hothorn, T.
Graeven, U.
Arnold, D.
Lang-Welzenbach, M.
Raab, H. -R
Suelberg, H.
Wittekind, C.
Potapov, S.
Staib, L.
Hess, C. F.
Weigang-Koehler, K.
Grabenbauer, G. G.
Hoffmans, H.
Lindemann, F.
Schlenska-Lange, A.
Folprecht, G.
Sauer, R.
STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 38 - 38

← 1 2 3 4 5 →